In less than 36 hours between the evening of Jan. 12 and the morning of Jan. 14, three local life science companies raised a ...

Umoja, founded in 2019, is developing in-body treatments to boost the effectiveness of immune cell therapies, targeting both ...

Updates include stronger alignment with the science of reading and supports for multilingual learners.Durham, N.C., Jan. 28, ...

You’ve certainly heard about antibodies, peptides, and even DNA as therapeutics, but what about RNA? In this review, we take a look at what’s happening in a field that some believe may be as big a ...

After hours: January 24 at 7:42:08 PM EST Loading Chart for GPCR ...

Vast Therapeutics is celebrating the new year with Series A funding in excess of $15 million from Shionogi & Co., Ltd. (TYO: 4507) of Japan and a $300,000 award from the Cystic Fibrosis Foundation.

Sanofi S.A. Part Cert 0.06% €8.19M ...

“It’s not an easy life, but it is challenging and rewarding to be a part of this industry.” Tune Therapeutics, an epigenome-editing company with origins at Duke University, has raised over $175 ...

North Carolina-based biotech Tune Therapeutics has raised $175 million in a Series B that will help it to take its lead epigenetic silencing drug, Tune-401, into clinical testing as a potential ...

There's great news for fans of The Traitors as, with the outcome of this series looking set o go right down to the wire after a huge twist, the final has been extended, meaning the show will begin ...